Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib
Clinical trial NCT06135194 · UNKNOWN
Trial details
- NCT number
- NCT06135194
- Sponsor
- Beijing 302 Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.